Sep 2026· International Journal of Women's Health· Vol 18· 0 citations· 42 references
Medicine
TL;DR
Based on the comorbidity characteristics of thyroid and breast diseases, the current status of comorbidity in the Chinese female population is dissected and associated factors are explored to provide more accurate and systematic countermeasures for improving women’s health.
Abstract
Background Breast cancer and thyroid cancer are common malignancies in Chinese women. The incidence and mortality rates of both cancers are increasing, seriously endangering the health of Chinese women. The association between these two diseases has drawn attention, yet research focusing on their comorbidity remains relatively limited. Methods We conducted a secondary analysis of data collected from a study that examined the health status of 17,086 women aged 25–55 years who underwent physical examinations at a tertiary hospital in China. Results The results showed that nearly half of the women had comorbidities. Age, BMI, hypertension, diabetes, uterine fibroids, lung disease, liver disease and kidney disease differed among the three groups of women, ie, those without thyroid or breast disease, those with a single thyroid/breast disease, and those with thyroid-breast comorbidity (all P < 0.05). Hypertension (OR = 1.434, 95% CI: 1.063–1.934), overweight or obesity (OR = 1.472, 95% CI: 1.211–1.788), kidney disease (OR = 1.424, 95% CI: 1.161–1.747), and uterine fibroids (OR = 2.542, 95% CI: 1.879–3.439) were associated factors for thyroid-breast comorbidity in women. Conclusion Based on the comorbidity characteristics of thyroid and breast diseases, this study aims to integrate thyroid disease and breast disease, dissect the current status of comorbidity in the Chinese female population, and further explore associated factors to provide more accurate and systematic countermeasures for improving women’s health.
It is concluded that high levels of free T3, and a high free T3/T4 ratio were associated with a lower risk of all‐cause mortality and may be a marker of a favourable prognosis.
Annie Brange, Ylva Heyman, Kamil Demircan et al.· Cancer Medicine· 0 citations
In this large cohort of Black women, poorer cardiometabolic health was associated with higher ER+ and lower ER- breast cancer risk among postmenopausal women, and divergent associations support a role for metabolic-endocrine crosstalk in breast cancer etiology.
Yifei Shan, Sarah M. Rothbard, Lynn Rosenberg et al.· International Journal of Can...· 0 citations
There was an increased risk of developing TC in all groups, and Black patients had the highest HR highlighting an area that warrants further investigation, and Black patients had the highest HR highlighting an area that warrants further investigation.
Rachael Caretti, Raj Roy, H. Arain et al.· The American surgeon· 0 citations
Background As long-term survival rates improve among thyroid cancer patients, the metabolic consequences of thyroidectomy and thyroid hormone therapy have gained increasing importance. While these treatments are crucial for cancer management, their long-term effects on metabolic health remain inadequately understood. M...
Ji-Woo Lee, C. Kim, Yeonjae Kim et al.· Frontiers in Endocrinology· 0 citations
Higher levels of general and central adiposity were associated with a higher risk of breast cancer, in both women who were premenopausal and women who were post-menopausal at baseline in this cohort of Chinese women.
C. Kartsonaki, N. Wright, I. Millwood et al.· International Journal of Epi...· 0 citations
Aim
. To evaluate the associations of anemia with various cardiovascular disease (CVD) risk factors, comorbidity, and mortality risk in individuals aged ≥55, depending on gender.
Material and methods
. The analysis included data from the prospective cohort study "Stress, Aging and Health Study in Russia" (SAHR...
A. Imaeva, N. A. Imaeva, Y. Balanova et al.· CARDIOVASCULAR THERAPY AND P...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.